GlassScriptPhysician profile
Rebecca Workman
NPI 1447695739
$2,870.90
in general payments reported to CMS, 2019-2025
21 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $554 · 2022: $174 · 2023: $91.75 · 2024: $1,424 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $992 · Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $992.45 |
| Food and Beverage | $933.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $992.45 | 2024 | |
| Lilly USA, LLC | $397.61 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $211.84 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $177.29 | 2019-2024 | Airsupra |
| Centinel Spine, LLC | $154.71 | 2022 | |
| Novo Nordisk INC | $138.60 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $103.20 | 2019-2025 | Evenity, Tepezza |
| Glaxosmithkline, LLC. | $96.48 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $92.12 | 2024-2025 | |
| Exact Sciences Corporation | $86.79 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.78 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $72.77 | 2019-2020 | |
| Abbvie INC. | $59.31 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $40.53 | 2020-2025 | Capvaxive |
| Phadia US INC. | $35.53 | 2019-2025 | Immunocap |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $34.96 | 2020 | |
| Janssen Pharmaceuticals, INC | $32.65 | 2020 | |
| Astellas Pharma US INC | $20.45 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.88 | 2025 | |
| Opko Pharmaceuticals, LLC | $14.21 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.